Atorvastatin
HMG-CoA Reductase Inhibitor (Statin)- Drug Class
- HMG-CoA Reductase Inhibitor (Statin)
- Mechanism of Action (MOA)
- Inhibits HMG-CoA reductase → ↓ hepatic cholesterol synthesis → upregulates LDL receptors → ↓ LDL.
- Clinical Notes
- Monitor for myopathy/rhabdo (esp. with fibrates) and transaminitis.
- Source
- FDA label
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Used for
Same family
Got a pharmacology lecture that covers Atorvastatin? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology